784 results on '"Mandrup‐Poulsen, Thomas"'
Search Results
2. Circadian desynchronization desensitizes insulin-producing cells to cytokine-mediated transcriptomic remodeling and cell death: a novel beta-cell anti-apoptotic response to inflammation
3. Tipping-point transition from transient to persistent inflammation in pancreatic islets.
4. Tipping-point transition from transient to persistent inflammation in pancreatic islets
5. Nutrient Abundance Signals the Changing of the Seasons by Phosphorylating PER2
6. Proinflammatory cytokines suppress nonsense-mediated RNA decay to impair regulated transcript isoform processing in pancreatic β cells.
7. Proinflammatory Cytokines, but not Glucolipotoxicity, Suppress Nonsense-Mediated RNA Decay to Impair Regulated Transcript Isoform Processing in Pancreatic β-Cells
8. Age-dependent transition from islet insulin hypersecretion to hyposecretion in mice with the long QT-syndrome loss-of-function mutation Kcnq1-A340V
9. Targeting innate immune mediators in type 1 and type 2 diabetes
10. Indomethacin Treatment Prevents High Fat Diet-induced Obesity and Insulin Resistance but Not Glucose Intolerance in C57BL/6J Mice*
11. Detrimental Actions of Chlorinated Nucleosides on the Function and Viability of Insulin-Producing Cells
12. S280: INDIVIDUALS WITH HFE C282Y HOMOZYGOSITY AND DIABETES HAVE ALMOST TWO-FOLD RISK OF DEATH COMPARED TO NON-CARRIERS WITH DIABETES: A PROSPECTIVE STUDY OF A 132,542-INDIVIDUAL GENERAL POPULATION COHORT
13. Lysine demethylase inhibition protects pancreatic β cells from apoptosis and improves β-cell function
14. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
15. Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients
16. No direct effect of SGLT2 activity on glucagon secretion
17. Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials
18. Effects of modified nucleosides on β-cell function – a contribution to islet dysfunction in Type 2 diabetes?
19. Pancreatic β-cells respond to fuel pressure with an early metabolic switch
20. Suppressor of Cytokine Signaling 3 (SOCS-3) Protects β-Cells against Interleukin-1 β- and Interferon-γ-Mediated Toxicity
21. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice
22. Interaction between dietary iron intake and genetically determined iron overload: risk of islet autoimmunity and progression to type 1 diabetes in the TEDDY study
23. FK506-Binding Protein 2 Participates in Proinsulin Folding
24. Obesity‐induced changes in gene expression in feline adipose and skeletal muscle tissue
25. Obesity‐induced changes in gene expression in feline adipose and skeletal muscle tissue
26. Author Correction: A guiding map for inflammation
27. Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice
28. FK506-binding protein 2 participates in proinsulin folding
29. A guiding map for inflammation
30. A randomized, double‐blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women
31. IMMUNOMETABOLISM IN 2017: Metabolism and the inflammasome in health and ageing
32. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection
33. Interaction Between Dietary Iron Intake and Genetically Determined Iron Overload: Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in the TEDDY Study.
34. Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk
35. Beta cells and inflammation in diabetes
36. Celebrities in the heart, strangers in the pancreatic beta cell:Voltage-gated potassium channels Kv7.1 and Kv11.1 bridge long QT syndrome with hyperinsulinaemia as well as type 2 diabetes
37. TiSH — a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC, and HILIC
38. Divalent Metal Transporter 1 Regulates Iron-Mediated ROS and Pancreatic β Cell Fate in Response to Cytokines
39. A randomized, double‐blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women.
40. Defective Proinsulin Handling Modulates the MHC I Bound Peptidome and Activates the Inflammasome in β-Cells
41. A Blunted GPR183/Oxysterol Axis During Dysglycemia Results in Delayed Recruitment of Macrophages to the Lung During Mycobacterium tuberculosis Infection
42. Celebrities in the heart, strangers in the pancreatic beta cell: Voltage‐gated potassium channels K v 7.1 and K v 11.1 bridge long QT syndrome with hyperinsulinaemia as well as type 2 diabetes
43. Inhibition of beta cell growth and function by bone morphogenetic proteins
44. The Fas Pathway Is Involved in Pancreatic β Cell Secretory Function
45. Defective proinsulin handling modulates the MHC I bound peptidome and activates the inflammasome in β-cells
46. The role of RNA oxidation in islet dysfunction in Type 2 diabetes
47. MicroRNAs as regulators of beta-cell function and dysfunction
48. Skeletal Muscle to Pancreatic β-Cell Cross-talk: The Effect of Humoral Mediators Liberated by Muscle Contraction and Acute Exercise on β-Cell Apoptosis
49. The Autoimmune Hypothesis of Insulin-Dependent Diabetes: 1965 to the Present
50. Divalent Metal Transporter 1 Knock-Down Modulates IL-1β Mediated Pancreatic Beta-Cell Pro-Apoptotic Signaling Pathways through the Autophagic Machinery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.